{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T04:44:06Z","timestamp":1745815446110,"version":"3.37.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-02999-1","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T13:03:09Z","timestamp":1668430989000},"page":"859-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of toll-like receptors (TLRs) and their therapeutic applications in endometrial cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Sahereh","family":"Arabian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aynaz","family":"Boostan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-4244","authenticated-orcid":false,"given":"Satinik","family":"Darzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"2","key":"2999_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10552-019-1129-1","volume":"30","author":"OW Scott","year":"2019","unstructured":"Scott OW, Tin ST, Bigby SM, Elwood JM. Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand. Cancer Causes Control. 2019;30(2):121\u20137.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2999_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ogc.2018.09.006","volume":"46","author":"ME McDonald","year":"2019","unstructured":"McDonald ME, Bender DP. Endometrial cancer: obesity, genetics, and targeted agents. Obstet Gynecol Clin. 2019;46(1):89\u2013105.","journal-title":"Obstet Gynecol Clin"},{"issue":"9484","key":"2999_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. The Lancet. 2005;366(9484):491\u2013505.","journal-title":"The Lancet"},{"key":"2999_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijgo.12612","volume":"143","author":"F Amant","year":"2018","unstructured":"Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynecol Obstet. 2018;143:37\u201350.","journal-title":"Int J Gynecol Obstet"},{"key":"2999_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jri.2014.12.006","volume":"109","author":"A Vanderstraeten","year":"2015","unstructured":"Vanderstraeten A, Tuyaerts S, Amant F. The immune system in the normal endometrium and implications for endometrial cancer development. J Reprod Immunol. 2015;109:7\u201316.","journal-title":"J Reprod Immunol"},{"key":"2999_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fimmu.2017.00172","volume":"8","author":"RM Guzman-Genuino","year":"2017","unstructured":"Guzman-Genuino RM, Diener KR. Regulatory B cells in pregnancy: lessons from autoimmunity, graft tolerance, and cancer. Front Immunol. 2017;8:172.","journal-title":"Front Immunol"},{"key":"2999_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/0-387-24180-9_2","volume-title":"Mechanisms of lymphocyte activation and immune regulation X","author":"C Pasare","year":"2005","unstructured":"Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. In: Min H, editor. Mechanisms of lymphocyte activation and immune regulation X. Springer; 2005. p. 11\u20138."},{"issue":"6","key":"2999_CR8","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/cells10061374","volume":"10","author":"J Aluri","year":"2021","unstructured":"Aluri J, Cooper MA, Schuettpelz LG. Toll-like receptor signaling in the establishment and function of the immune system. Cells. 2021;10(6):1374.","journal-title":"Cells"},{"issue":"2","key":"2999_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jcmm.16214","volume":"25","author":"Y Mokhtari","year":"2021","unstructured":"Mokhtari Y, Pourbagheri-Sigaroodi A, Zafari P, Bagheri N, Ghaffari SH, Bashash D. Toll-like receptors (TLRs): an old family of immune receptors with a new face in cancer pathogenesis. J Cell Mol Med. 2021;25(2):639\u201351.","journal-title":"J Cell Mol Med"},{"key":"2999_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-030-44518-8_9","volume-title":"Tumor microenvironment","author":"M Angrini","year":"2020","unstructured":"Angrini M, Varthaman A, Cremer I. Toll-like receptors (TLRs) in the tumor microenvironment (TME): a dragon-like weapon in a non-fantasy game of thrones. In: Tumor microenvironment. Springer; 2020. p. 145\u201373."},{"key":"2999_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9912188","volume":"2021","author":"S Pahlavanneshan","year":"2021","unstructured":"Pahlavanneshan S, Sayadmanesh A, Ebrahimiyan H, Basiri M. Toll-Like receptor-based strategies for cancer immunotherapy. J Immunol Res. 2021;2021:1\u201314.","journal-title":"J Immunol Res"},{"issue":"3","key":"2999_CR12","first-page":"709","volume":"13","author":"M Ferdeghini","year":"1993","unstructured":"Ferdeghini M, Gadducci A, Prontera C, Marrai R, Malagnino G, Annicchiarico C, et al. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data. Anticancer Res. 1993;13(3):709\u201313.","journal-title":"Anticancer Res"},{"issue":"3","key":"2999_CR13","first-page":"145","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA: Cancer J Clin. 2020;70(3):145\u201364.","journal-title":"CA: Cancer J Clin"},{"issue":"10023","key":"2999_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. The Lancet. 2016;387(10023):1094\u2013108.","journal-title":"The Lancet"},{"issue":"2","key":"2999_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00006250-200508000-00050","volume":"106","author":"Obstetricians ACo, Gynecologists","year":"2005","unstructured":"Obstetricians ACo, Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106(2):413\u201325.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2999_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/modpathol.3800620","volume":"19","author":"M Reid-Nicholson","year":"2006","unstructured":"Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol. 2006;19(8):1091\u2013100.","journal-title":"Mod Pathol"},{"issue":"1","key":"2999_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","volume":"26","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonz\u00e1lez-Mart\u00edn A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer. 2016;26(1):2\u201330.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2999_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.24869\/psyd.2021.569","volume":"33","author":"A Sahin Ekici","year":"2021","unstructured":"Sahin Ekici A, Sahin S, Demir B, Elboga G, Altindag A. A case of catatonia related to infective endocarditis during pregnancy. Psychiatr Danub. 2021;33(4):569\u201370.","journal-title":"Psychiatr Danub"},{"issue":"suppl 4","key":"2999_CR19","first-page":"632","volume":"33","author":"B \u0160kegro","year":"2021","unstructured":"\u0160kegro B, Bjedov S, Miku\u0161 M, Musta\u010d F, Le\u0161in J, Matijevi\u0107 V, et al. Endometriosis, pain and mental health. Psychiatr Danub. 2021;33(suppl 4):632\u20136.","journal-title":"Psychiatr Danub"},{"key":"2999_CR20","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.ijbiomac.2020.07.293","volume":"161","author":"BR Sahoo","year":"2020","unstructured":"Sahoo BR. Structure of fish Toll-like receptors (TLR) and NOD-like receptors (NLR). Int J Biol Macromol. 2020;161:1602\u201317.","journal-title":"Int J Biol Macromol"},{"key":"2999_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.557638","volume":"10","author":"Y Gao","year":"2020","unstructured":"Gao Y, Chen S, Vafaei S, Zhong X. Tumor-infiltrating immune cell signature predicts the prognosis and chemosensitivity of patients with pancreatic ductal adenocarcinoma. Front Oncol. 2020;10: 557638.","journal-title":"Front Oncol"},{"issue":"5","key":"2999_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1042\/bst0280563","volume":"28","author":"M Muzio","year":"2000","unstructured":"Muzio M, Polentarutti N, Bosisio D, Kumar PM, Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans. 2000;28(5):563\u20136.","journal-title":"Biochem Soc Trans"},{"key":"2999_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1412s109","author":"K Takeda","year":"2015","unstructured":"Takeda K, Akira S. Toll-like receptors. Curr Protocols Immunol. 2015. https:\/\/doi.org\/10.1002\/0471142735.im1412s109.","journal-title":"Curr Protocols Immunol"},{"issue":"7147","key":"2999_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nature05836","volume":"447","author":"SL Foster","year":"2007","unstructured":"Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007;447(7147):972\u20138.","journal-title":"Nature"},{"key":"2999_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.imlet.2022.03.004","volume":"245","author":"M Rajabinejad","year":"2022","unstructured":"Rajabinejad M, Asadi G, Ranjbar S, Varmaziar FR, Karimi M, Salari F, et al. The MALAT1-H19\/miR-19b-3p axis can be a fingerprint for diabetic neuropathy. Immunol Lett. 2022;245:69\u201378.","journal-title":"Immunol Lett"},{"issue":"12","key":"2999_CR26","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/s12276-020-00540-4","volume":"52","author":"G-Y Jang","year":"2020","unstructured":"Jang G-Y, Kim YS, Lee SE, Han HD, Hong K-J, Kang TH, et al. Interactions between tumor-derived proteins and Toll-like receptors. Exp Mol Med. 2020;52(12):1926\u201335.","journal-title":"Exp Mol Med"},{"issue":"252","key":"2999_CR27","first-page":"1443","volume":"31","author":"S Vafaei","year":"2013","unstructured":"Vafaei S, Mirnejad R, Amirmozafari N. Determining the patterns of antimicrobial susceptibility and the distribution of blaCTX-M genes in strains of Acinetobacter Baumannii isolated from clinical samples. J Isfahan Med School. 2013;31(252):1443\u201351.","journal-title":"J Isfahan Med School"},{"key":"2999_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.","journal-title":"Front Immunol"},{"issue":"7","key":"2999_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499\u2013511.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2999_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/0008-5472.CAN-19-1023","volume":"80","author":"Y-Y Qu","year":"2020","unstructured":"Qu Y-Y, Zhao R, Zhang H-L, Zhou Q, Xu F-J, Zhang X, et al. Inactivation of the AMPK\u2013GATA3\u2013ECHS1 pathway induces fatty acid synthesis that promotes clear cell renal cell carcinoma growth. Can Res. 2020;80(2):319\u201333.","journal-title":"Can Res"},{"issue":"11","key":"2999_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","volume":"13","author":"T Kawai","year":"2007","unstructured":"Kawai T, Akira S. Signaling to NF-\u03baB by Toll-like receptors. Trends Mol Med. 2007;13(11):460\u20139.","journal-title":"Trends Mol Med"},{"issue":"6","key":"2999_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/08820139.2018.1480029","volume":"47","author":"P Zafari","year":"2018","unstructured":"Zafari P, Yari K, Mostafaei S, Iranshahi N, Assar S, Fekri A, et al. Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients. Immunol Invest. 2018;47(6):632\u201342.","journal-title":"Immunol Invest"},{"issue":"6","key":"2999_CR33","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1007\/s11033-019-05078-x","volume":"46","author":"Z Samimi","year":"2019","unstructured":"Samimi Z, Kardideh B, Zafari P, Bahrehmand F, Roghani SA, Taghadosi M. The impaired gene expression of adenosine monophosphate-activated kinase (AMPK), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients. Mol Biol Rep. 2019;46(6):6353\u201360.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2999_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1172\/JCI11837","volume":"107","author":"G Zhang","year":"2001","unstructured":"Zhang G, Ghosh S. Toll-like receptor\u2013mediated NF-\u03baB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Investig. 2001;107(1):13\u20139.","journal-title":"J Clin Investig"},{"issue":"8","key":"2999_CR35","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.1021\/acs.nanolett.0c01757","volume":"20","author":"J Yan","year":"2020","unstructured":"Yan J, Yao Y, Yan S, Gao R, Lu W, He W. Chiral protein supraparticles for tumor suppression and synergistic immunotherapy: an enabling strategy for bioactive supramolecular chirality construction. Nano Lett. 2020;20(8):5844\u201352.","journal-title":"Nano Lett"},{"key":"2999_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jconrel.2022.05.062","volume":"349","author":"C Liu","year":"2022","unstructured":"Liu C, Wang Y, Li L, He D, Chi J, Li Q, et al. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J Control Release. 2022;349:679\u201398.","journal-title":"J Control Release"},{"issue":"9","key":"2999_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.it.2012.05.002","volume":"33","author":"T Kondo","year":"2012","unstructured":"Kondo T, Kawai T, Akira S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 2012;33(9):449\u201358.","journal-title":"Trends Immunol"},{"issue":"4","key":"2999_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/08820139.2018.1549066","volume":"48","author":"N Iranshahi","year":"2019","unstructured":"Iranshahi N, Assar S, Amiri SM, Zafari P, Fekri A, Taghadosi M. Decreased gene expression of Epstein-Barr Virus-Induced Gene 3 (EBI-3) may contribute to the pathogenesis of rheumatoid arthritis. Immunol Invest. 2019;48(4):367\u201377.","journal-title":"Immunol Invest"},{"issue":"3","key":"2999_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2567.2004.01898.x","volume":"112","author":"TM Schaefer","year":"2004","unstructured":"Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. Toll-like receptor (TLR) expression and TLR-mediated cytokine\/chemokine production by human uterine epithelial cells. Immunology. 2004;112(3):428\u201336.","journal-title":"Immunology"},{"issue":"9","key":"2999_CR40","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00262-008-0650-y","volume":"58","author":"M Zhou","year":"2009","unstructured":"Zhou M, McFarland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T, Drew AF. Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother. 2009;58(9):1375\u201385.","journal-title":"Cancer Immunol Immunother"},{"issue":"3\u20134","key":"2999_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1368-7646(02)00003-1","volume":"5","author":"JQ Cheng","year":"2002","unstructured":"Cheng JQ, Jiang X, Fraser M, Li M, Dan HC, Sun M, et al. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase\/Akt pathway. Drug Resist Updat. 2002;5(3\u20134):131\u201346.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"2999_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1525-1438.2007.01008.x","volume":"18","author":"WY Kim","year":"2008","unstructured":"Kim WY, Lee JW, Choi JJ, Choi CH, Kim TJ, Kim BG, et al. Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer. 2008;18(2):300\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"2999_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/mc.20325","volume":"46","author":"JW Lee","year":"2007","unstructured":"Lee JW, Choi JJ, Seo ES, Kim MJ, Kim WY, Choi CH, et al. Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog. 2007;46(11):941\u20137.","journal-title":"Mol Carcinog"},{"issue":"8","key":"2999_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5603\/GP.2020.0073","volume":"91","author":"KM Wojcik-Krowiranda","year":"2020","unstructured":"Wojcik-Krowiranda KM, Forma E, Bienkiewicz A, Cwonda L, Wronska-Stefaniak J, Brys M. TLR family gene expression in relation to the HIF1\u03b1 and the VEGFR pathway activation in endometrial cancer. Ginekol Pol. 2020;91(8):439\u201346.","journal-title":"Ginekol Pol"},{"issue":"1","key":"2999_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"X-H Wang","year":"2021","unstructured":"Wang X-H, Xu S, Zhou X-Y, Zhao R, Lin Y, Cao J, et al. Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk. Nat Commun. 2021;12(1):1\u201314.","journal-title":"Nat Commun"},{"key":"2999_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-065X.2007.00579.x","volume":"220","author":"MT Lotze","year":"2007","unstructured":"Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, et al. The grateful dead: damage-associated molecular pattern molecules and reduction\/oxidation regulate immunity. Immunol Rev. 2007;220:60\u201381.","journal-title":"Immunol Rev"},{"key":"2999_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1477-7827-6-40","volume":"6","author":"S Allhorn","year":"2008","unstructured":"Allhorn S, B\u00f6ing C, Koch AA, Kimmig R, Gashaw I. TLR3 and TLR4 expression in healthy and diseased human endometrium. Reprod Biol Endocrinol. 2008;6:40.","journal-title":"Reprod Biol Endocrinol"},{"key":"2999_CR48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/1471-2407-10-382","volume":"10","author":"KA Ashton","year":"2010","unstructured":"Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, et al. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer. 2010;10:382.","journal-title":"BMC Cancer"},{"issue":"3","key":"2999_CR49","first-page":"196","volume":"52","author":"BB Gen\u00e7o\u011flu Bakbak","year":"2018","unstructured":"Gen\u00e7o\u011flu Bakbak BB, Ilhan TT, Pekin A, Kerimo\u011flu \u00d6S, Y\u0131lmaz SA, Kebap\u00e7\u0131lar A, et al. Evaluation of toll-like receptor expression with clinicopathologic variables in endometrium cancer. Sisli Etfal Hastan Tip Bul. 2018;52(3):196\u2013200.","journal-title":"Sisli Etfal Hastan Tip Bul"},{"issue":"14","key":"2999_CR50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob J-J, Cowey CL, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377(14):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"14","key":"2999_CR51","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","volume":"378","author":"RJ Motzer","year":"2018","unstructured":"Motzer RJ, Tannir NM, McDermott DF, Frontera OA, Melichar B, Choueiri TK, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. New Engl J Med. 2018;378(14):1277\u201390.","journal-title":"New Engl J Med"},{"issue":"2","key":"2999_CR52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10787-022-00933-z","volume":"30","author":"H Azadeh","year":"2022","unstructured":"Azadeh H, Alizadeh-Navaei R, Rezaiemanesh A, Rajabinejad M. Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis. Inflammopharmacology. 2022;30(2):435\u201351.","journal-title":"Inflammopharmacology"},{"key":"2999_CR53","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e46","author":"C Di Tucci","year":"2019","unstructured":"Di Tucci C, Capone C, Galati G, Iacobelli V, Schiavi MC, Di Donato V, et al. Immunotherapy in endometrial cancer: new scenarios on the horizon. J Gynecol Oncol. 2019. https:\/\/doi.org\/10.3802\/jgo.2019.30.e46.","journal-title":"J Gynecol Oncol"},{"issue":"7447","key":"2999_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"G Getz","year":"2013","unstructured":"Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, Sougnez C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"issue":"2","key":"2999_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/jjco\/hyaa214","volume":"51","author":"H Nishio","year":"2021","unstructured":"Nishio H, Iwata T, Aoki D. Current status of cancer immunotherapy for gynecologic malignancies. Jpn J Clin Oncol. 2021;51(2):167\u201372.","journal-title":"Jpn J Clin Oncol"},{"key":"2999_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2018.05.011","volume":"128","author":"C Di Tucci","year":"2018","unstructured":"Di Tucci C, Schiavi MC, Faiano P, D\u2019Oria O, Prata G, Sciuga V, et al. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers. Crit Rev Oncol Hematol. 2018;128:30\u201342.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2999_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/rmb2.12083","volume":"17","author":"KN Khan","year":"2018","unstructured":"Khan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, Fushiki S, et al. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17(2):125\u201333.","journal-title":"Reprod Med Biol"},{"issue":"10","key":"2999_CR58","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1631\/jzus.B1900071","volume":"20","author":"H Zhang","year":"2019","unstructured":"Zhang H, Wu ZM, Yang YP, Shaukat A, Yang J, Guo YF, et al. Catalpol ameliorates LPS-induced endometritis by inhibiting inflammation and TLR4\/NF-\u03baB signaling. J Zhejiang Univ Sci B. 2019;20(10):816\u201327.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"9","key":"2999_CR59","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/abbs\/gmab095","volume":"53","author":"Y Lin","year":"2021","unstructured":"Lin Y, Li Y, Li X, Liu X, Wang X, Yu M, et al. SCM-198 ameliorates endometrial inflammation via suppressing the LPS-JNK-cJUN\/cFOS-TLR4-NF-\u03baB pathway. Acta Biochim Biophys Sin (Shanghai). 2021;53(9):1207\u201315.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1\u20132","key":"2999_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000513590","volume":"86","author":"A Ghanavatinejad","year":"2021","unstructured":"Ghanavatinejad A, Rashidi N, Mirahmadian M, Rezania S, Mosalaei M, Ghasemi J, et al. Vitamin D3 controls TLR4- and TLR2-mediated inflammatory responses of endometrial cells. Gynecol Obstet Invest. 2021;86(1\u20132):139\u201348.","journal-title":"Gynecol Obstet Invest"},{"issue":"Suppl 9","key":"2999_CR61","first-page":"S31","volume":"98","author":"N Buathong","year":"2015","unstructured":"Buathong N, Poonyachoti S, Deachapunya C. Isoflavone genistein modulates the protein expression of toll-like receptors in cancerous human endometrial cells. J Med Assoc Thai. 2015;98(Suppl 9):S31\u20138.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"2999_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10753-018-0874-8","volume":"42","author":"M Zhou","year":"2019","unstructured":"Zhou M, Yi Y, Hong L. Oridonin ameliorates lipopolysaccharide-induced endometritis in mice via inhibition of the TLR-4\/NF-\u03baBpathway. Inflammation. 2019;42(1):81\u201390.","journal-title":"Inflammation"},{"issue":"1","key":"2999_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jcmm.14744","volume":"24","author":"K Jiang","year":"2020","unstructured":"Jiang K, Yang J, Yang C, Zhang T, Shaukat A, Yang X, et al. miR-148a suppresses inflammation in lipopolysaccharide-induced endometritis. J Cell Mol Med. 2020;24(1):405\u201317.","journal-title":"J Cell Mol Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-02999-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-02999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:08:58Z","timestamp":1731344938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-02999-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2999"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-02999-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"It is not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}